Growth Metrics

Novartis Ag (NVS) Total Debt (2016 - 2025)

Novartis Ag's Total Debt history spans 11 years, with the latest figure at $28.7 billion for Q4 2025.

  • On a quarterly basis, Total Debt rose 30.54% to $28.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $28.7 billion, a 30.54% increase, with the full-year FY2025 number at $28.7 billion, up 30.54% from a year prior.
  • Total Debt hit $28.7 billion in Q4 2025 for Novartis Ag, up from $22.0 billion in the prior quarter.
  • Over the last five years, Total Debt for NVS hit a ceiling of $29.2 billion in Q4 2021 and a floor of $868.0 million in Q2 2021.
  • Historically, Total Debt has averaged $18.6 billion across 5 years, with a median of $20.5 billion in 2023.
  • Biggest five-year swings in Total Debt: crashed 96.45% in 2021 and later soared 734.68% in 2022.
  • Tracing NVS's Total Debt over 5 years: stood at $29.2 billion in 2021, then fell by 10.35% to $26.2 billion in 2022, then fell by 27.18% to $19.1 billion in 2023, then rose by 15.47% to $22.0 billion in 2024, then surged by 30.54% to $28.7 billion in 2025.
  • Business Quant data shows Total Debt for NVS at $28.7 billion in Q4 2025, $22.0 billion in Q4 2024, and $19.1 billion in Q4 2023.